GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (XSWX:STMN) » Definitions » Net Cash per Share

Straumann Holding AG (XSWX:STMN) Net Cash per Share : CHF-6.73 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Straumann Holding AG Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Straumann Holding AG's Net Cash per Share for the quarter that ended in Dec. 2023 was CHF-6.73.

The historical rank and industry rank for Straumann Holding AG's Net Cash per Share or its related term are showing as below:

During the past 13 years, the highest Price-to-Net-Cash Ratio of Straumann Holding AG was 104.48. The lowest was 104.48. And the median was 104.48.

XSWX:STMN's Price-to-Net-Cash is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 7.16
* Ranked among companies with meaningful Price-to-Net-Cash only.

Straumann Holding AG Net Cash per Share Historical Data

The historical data trend for Straumann Holding AG's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG Net Cash per Share Chart

Straumann Holding AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.82 -4.48 -3.71 -5.18 -6.73

Straumann Holding AG Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.71 -4.41 -5.18 -5.80 -6.73

Competitive Comparison of Straumann Holding AG's Net Cash per Share

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Straumann Holding AG's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's Price-to-Net-Cash falls into.



Straumann Holding AG Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Straumann Holding AG's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(413.537-1483.373-2.427)/159.443
=-6.73

Straumann Holding AG's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(413.537-1483.373-2.427)/159.443
=-6.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Straumann Holding AG  (XSWX:STMN) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


Straumann Holding AG Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Straumann Holding AG (XSWX:STMN) Business Description

Traded in Other Exchanges
Address
Peter Merian-Weg 12, Basel, CHE, 4002
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (XSWX:STMN) Headlines

No Headlines